Home
>
National Drug Code (NDC)
>
Deferoxamine
Deferoxamine - 63323-599-30 - (DEFEROXAMINE MESYLATE)
Drug Information of Deferoxamine
| Product NDC: | 63323-599 |
| Proprietary Name: | Deferoxamine |
| Non Proprietary Name: | DEFEROXAMINE MESYLATE |
| Active Ingredient(s): | 95 mg/mL & nbsp; DEFEROXAMINE MESYLATE |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Deferoxamine
| Product NDC: | 63323-599 |
| Labeler Name: | APP Pharmaceuticals, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078718 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20091215 |
Package Information of Deferoxamine
| Package NDC: | 63323-599-30 |
| Package Description: | 1 VIAL in 1 BOX (63323-599-30) > 21.1 mL in 1 VIAL |
NDC Information of Deferoxamine
| NDC Code | 63323-599-30 |
| Proprietary Name | Deferoxamine |
| Package Description | 1 VIAL in 1 BOX (63323-599-30) > 21.1 mL in 1 VIAL |
| Product NDC | 63323-599 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | DEFEROXAMINE MESYLATE |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| Start Marketing Date | 20091215 |
| Marketing Category Name | ANDA |
| Labeler Name | APP Pharmaceuticals, LLC |
| Substance Name | DEFEROXAMINE MESYLATE |
| Strength Number | 95 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Iron Chelating Activity [MoA],Iron Chelator [EPC] |
